Aurelia Raducanu

Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy

The pathological changes in osteoarthritis--a degenerative joint disease prevalent among older people--start at the molecular scale and spread to the higher levels of the architecture of articular cartilage to cause progressive and irreversible structural and functional damage. At present, there are no treatments to cure or attenuate the degradation of cartilage. Early detection and the ability to monitor the progression of osteoarthritis are therefore important for developing effective therapies. Here, we show that indentation-type atomic force microscopy can monitor age-related morphological and biomechanical changes in the hips of normal and osteoarthritic mice. Early damage in the cartilage of osteoarthritic patients undergoing hip or knee replacements could similarly be detected using this method. Changes due to aging and osteoarthritis are clearly depicted at the nanometre scale well before morphological changes can be observed using current diagnostic methods. Indentation-type atomic force microscopy may potentially be developed into a minimally invasive arthroscopic tool to diagnose the early onset of osteoarthritis in situ.

Lifeact mice for studying F-actin dynamics.

1. Richter, S.H., Garner, J.P. & Würbel, H. Nat. Methods 6, 257–261 (2009). 2. Beynen, A.C., Gärtner, K. & van Zutphen, L.F.M. in Principles of Laboratory Animal Science 2nd edn. (eds., van Zutphen, L.F.M., Baumans, V. & Beynen, A.C.) 103–110 (Elsevier, Amsterdam, 2003). 3. Würbel, H. Nat. Genet. 26, 263 (2000). 4. Crabbe, J.C., Wahlsten, D. & Dudek, B.C. Science 284, 1670–1672 (1999). 5. Paylor, R. Nat. Methods 6, 253–254 (2009). 6 . Larkin, J.E., Frank, B.C., Gavras, H. & Quackenbush, J. Nat. Methods 2, 337– 343 (2005). experiment standardization increased test sensitivity at the expense of reproducibility. To confirm this statistically, we used a GLM to compare the two experimental designs for the effect of the factor ‘experiment’ and of the ‘strain-by-experiment’ interaction term on the variance in behavioral measures (Supplementary Methods). As expected, ‘experiment’ had a significantly greater effect in the standardized design (F1,35 = 63.65, P < 0.001), indicating greater variation in the data between standardized experiments. As the effects of genotype and environment are rarely additive1,4, we also expected greater variation in strain differences between standardized experiments. Indeed, F ratios of the ‘strain-by-experiment’ interaction term were significantly lower in heterogenized experiments (F1,35 = 54.63, P < 0.001), confirming better reproducibility (Fig. 1d). To assess whether this was caused by heterogenization increasing within-experiment variation, thereby reducing between-experiment variation, we calculated the F ratio of the ‘strain-by-experiment’ term divided by the ‘strain-by-block’ term. These F ratios were significantly smaller in heterogenized experiments (F1,35 = 38.82, P < 0.001), confirming that heterogenization increased within-experiment variation relative to between-experiment variation (Fig. 2 and Supplementary Figs. 3 and 4). Moreover, in the heterogenized design this F ratio was nearly equal to 1 (t-test of the null hypothesis that F = 1: T35 = –1.12; nonsignificant), demonstrating that data for blocks between experiments differed no more than for blocks within experiments. Thus, systematic variation of only two factors was sufficient to mimic the range of differences between the replicate experiments, which guaranteed virtually perfect reproducibility. These findings empirically confirm that standardized experiments can generate spurious results by increasing test sensitivity at the expense of external validity1. However, even simple forms of heterogenization may render study populations sufficiently heterogeneous to guarantee robust results across the unavoidable variation between experiments. This has important implications for behavioral screening studies but may also apply to other areas of laboratory research that are fraught with poor reproducibility because of study-, siteand sample-specific idiosyncrasies6. 5,000

Homing of Mouse Spermatogonial Stem Cells to Germline Niche Depends on β1-Integrin

Spermatogonial stem cells (SSCs) provide the foundation for spermatogenesis. In a manner comparable to hematopoietic stem cell transplantation, SSCs colonize the niche of recipient testes and reinitiate spermatogenesis following microinjection into the seminiferous tubules. However, little is known about the homing mechanism of SSCs. Here we examined the role of adhesion molecules in SSC homing. SSCs isolated from mice carrying loxP-tagged beta1-integrin alleles were ablated for beta1-integrin expression by in vitro adenoviral cre transduction. The beta1-integrin mutant SSCs showed significantly reduced ability to recolonize recipient testes in vivo and to attach to laminin molecules in vitro. In contrast, genetic ablation of E-cadherin did not impair homing, and E-cadherin mutant SSCs completed normal spermatogenesis. In addition, the deletion of beta1-integrin on Sertoli cells reduced SSC homing. These results identify beta1-integrin as an essential adhesion receptor for SSC homing and its association with laminin is critical in multiple steps of SSC homing.

β1A integrin is a master regulator of invadosome organization and function.

Use of patterned surfaces, reverse genetics, and time-controlled photoinactivation showed that β1 but not β3 integrins are required for invadosome formation, self-assembly, and stabilization into a ring structure. The activation state of β1 as well as its phosphorylation by protein kinase C on Ser785 control these process and link to the degradative function.

β1 Integrin Deficiency Results in Multiple Abnormalities of the Knee Joint

The lack of β1 integrins on chondrocytes leads to severe chondrodysplasia associated with high mortality rate around birth. To assess the impact of β1 integrin-mediated cell-matrix interactions on the function of adult knee joints, we conditionally deleted the β1 integrin gene in early limb mesenchyme using the Prx1-cre transgene. Mutant mice developed short limbed dwarfism and had joint defects due to β1 integrin deficiency in articular regions. The articular cartilage (AC) was structurally disorganized, accompanied by accelerated terminal differentiation, altered shape, and disrupted actin cytoskeleton of the chondrocytes. Defects in chondrocyte proliferation, cytokinesis, and survival resulted in hypocellularity. However, no significant differences in cartilage erosion, in the expression of matrix-degrading proteases, or in the exposure of aggrecan and collagen II cleavage neoepitopes were observed between control and mutant AC. We found no evidence for disturbed activation of MAPKs (ERK1/2, p38, and JNK) in vivo. Furthermore, fibronectin fragment-stimulated ERK activation and MMP-13 expression were indistinguishable in control and mutant femoral head explants. The mutant synovium was hyperplastic and frequently underwent chondrogenic differentiation. β1-null synoviocytes showed increased proliferation and phospho-focal adhesion kinase expression. Taken together, deletion of β1 integrins in the limb bud results in multiple abnormalities of the knee joints; however, it does not accelerate AC destruction, perturb cartilage metabolism, or influence intracellular MAPK signaling pathways.

Knock-Out Mice in Osteoarthritis Research

Osteoarthritis (OA) is the most common degenerative disorder of the joints with an etiology involving genetic and environmental factors. Although various animal models have been used to elucidate the pathogenesis of OA, in the past decade gene targeting in mice has become one of the most powerful tools to dissect the molecular mechanisms of the disease. The generation of knockout mice has enormously accelerated the identification of the key genetic players in ar- ticular cartilage homeostasis and made a significant contribution to further our understanding of OA pathology. In this re- view, we will outline the phenotypes of the currently available mouse strains, carrying either engineered or spontaneous gene mutations, which provide insight into the processes of articular cartilage destruction. The analysis of these mice re- veals a complex interaction among cytokines, proteases, transcription factors, extracellular matrix, cell surface and signal- ing molecules during the initiation and progression of OA and, in some cases, suggests new therapeutic interventions for the disease.

The Membrane-targeted Alkylphosphocholine Erufosine Interferes with Survival Signals from the Extracellular Matrix

Integrin-dependent adhesion of tumor cells to extracellular matrix proteins provides anchorage-dependent protection from cell death. In the present investigation we aimed to understand whether and how the paradigmatic membrane-targeted synthetic phospholipid analog erufosine is relevant for tumor cell adhesion to extracellular matrix proteins, cell survival and migration. The antineoplastic action of erufosine was analyzed with glioblastoma and prostate cancer cells adhering to fibronectin or collagen I using proliferation, adhesion and migration assays. The composition of adhesion contacts containing activated β1 integrins was studied using immunofluorescence. The importance of β1 integrins for the observed effects was analyzed in fibroblasts proficient or deficient in β1 integrin expression. Adhesion to collagen I and fibronectin increased the death threshold in serum-deprived tumor cells. Moreover, β1 integrin-deficient cells were more sensitive to erufosine-treatment compared to β1 integrin proficient cells suggesting a role of β1 integrins for matrix-mediated death resistance. Most importantly, erufosine disturbed the maturation of the cell adhesion complexes containing paxillin, activated β1 integrins and phosphorylated FAK, leading to a reduction of survival signals and inhibition of tumor cell adhesion and migration. These findings suggest that membrane-targeted synthetic phospholipids analogs may be of value for counteracting matrix-mediated treatment resistance in combined treatment approaches with radiotherapy or chemotherapy.